2019 antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline

Overview

This report is the World Health Organization’s (WHO) third annual review of the clinical antibacterial pipeline to analyse how the pipeline responds to the WHO priority pathogens list. This report covers direct-acting small molecules and biological agents that are in development worldwide. It assesses to what extent the pipeline addresses the WHO priority pathogens, Mycobacterium tuberculosis and Clostridioides difficile and to what extent the antibacterial agents are innovative. This report is part of the WHO’s efforts in global research and development (R&D) priority setting to contain antimicrobial resistance.

All of the data contained in this report can be downloaded from the WHO Global Observatory on Health R&D